| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10835451 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 1462 journal articles in the PubMed database | Email to a friend | | |
| Schellinger PD, Jansen O, Fiebach JB, et al.
Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. [Journal Article]
Stroke 2000 Jun; 31(6):1318-28.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nighoghossian N, Hermier M, Adeleine P, et al.
Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator. [Clinical Trial, Journal Article]
Stroke 2003 Feb; 34(2):458-63.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Higashida RT, Furlan AJ, Roberts H, et al.
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. [Guideline, Journal Article, Practice Guideline]
Stroke 2003 Aug; 34(8):e109-37.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Röther J, Schellinger PD, Gass A, et al.
Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. [Clinical Trial, Journal Article, Multicenter Study]
Stroke 2002 Oct; 33(10):2438-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Derex L, Nighoghossian N, Hermier M, et al.
Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. [Clinical Trial, Journal Article]
J Neurol Sci 2004 Oct 15; 225(1-2):3-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Parsons MW, Barber PA, Chalk J, et al.
Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. [Clinical Trial, Controlled Clinical Trial, Journal Article]
Ann Neurol 2002 Jan; 51(1):28-37.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Thomalla G, Sobesky J, Köhrmann M, et al.
Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. [Journal Article, Research Support, Non-U.S. Gov't]
Stroke 2007 Feb; 38(2):313-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Schellinger PD, Fiebach JB, Jansen O, et al.
Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. [Journal Article]
Ann Neurol 2001 Apr; 49(4):460-9.
Abstract | Full Citation | Find Related Articles | | Hacke W, Albers G, Al-Rawi Y, et al.
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. [Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial]
Stroke 2005 Jan; 36(1):66-73.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
